Christiane Mendre
Affiliations: | Université de Montpellier I. UFR des sciences pharmaceutiques et biologiques (1968-2014) |
Google:
"Christiane Mendre"Children
Sign in to add traineeFrédéric Jean-Alphonse | grad student | 2008 | Université de Montpellier I. UFR des sciences pharmaceutiques et biologiques (1968-2014) |
Sanja Perkovska | grad student | 2009 | Univ. Montpellier 2 |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Fouillen A, Bous J, Couvineau P, et al. (2025) Inactive structures of the vasopressin V2 receptor reveal distinct binding modes for Tolvaptan and Mambaquaretin toxin. Nature Communications. 16: 3899 |
Fouillen A, Couvineau P, Gaibelet G, et al. (2024) Biased activation of the vasopressin V2 receptor probed by molecular dynamics simulations, NMR and pharmacological studies. Computational and Structural Biotechnology Journal. 23: 3784-3799 |
Stanajic-Petrovic G, Keck M, Barbe P, et al. (2024) MQ232, A Snake Toxin Derivative for Treatment of Hyponatremia and Polycystic Kidney Diseases. Journal of the American Society of Nephrology : Jasn |
Droctové L, Ciolek J, Mendre C, et al. (2022) A new Kunitz-type snake toxin family associated with an original mode of interaction with the vasopressin 2 receptor. British Journal of Pharmacology |
Hus-Citharel A, Bouby N, Corbani M, et al. (2021) Characterization of a functional V vasopressin receptor in the male rat kidney, evidence for crosstalk between V and V receptor signaling pathways. American Journal of Physiology. Renal Physiology |
Droctové L, Lancien M, Tran VL, et al. (2020) A snake toxin as a theranostic agent for the type 2 vasopressin receptor. Theranostics. 10: 11580-11594 |
Mendre C, Mouillac B. (2019) Misfolding of vasopressin receptors: biased agonist pharmacochaperones as potential therapeutics. Advances in Protein Chemistry and Structural Biology. 118: 249-272 |
Droctové L, Ciolek J, Lancien M, et al. (2018) Crystal structure and functional domains of the Mambaquaretin-1, a vasopressin type 2 receptor peptide inhibitor for kidney cysts treatment Toxicon. 149: 91-92 |
Perkovska S, Méjean C, Ayoub MA, et al. (2017) V1b vasopressin receptor trafficking and signaling : role of arrestins, G proteins and Src kinase. Traffic (Copenhagen, Denmark) |
Mouillac B, Mendre C. (2017) Pharmacological Chaperones as Potential Therapeutic Strategies for Misfolded Mutant Vasopressin Receptors. Handbook of Experimental Pharmacology |